By: Surjit Singh Flora
A national pharmacare agreement has been reached, and NDP leader Jagmeet Singh is celebrating it as a major win for his party. Definitely! This federal Pharmacare program also marks a significant achievement for Brampton South MP Sonia Sidhu, with her diabetes care plan being incorporated.
Diabetes is a widespread chronic condition in Canada, impacting millions of individuals nationwide.
At the Peel Memorial Centre for Integrated Health and Wellness, Member of Parliament for Brampton South, Sonia Sidhu, along with Dr. Frank Martino, President and CEO of William Osler Health System, hosted Prime Minister Justin Trudeau for an important discussion on diabetes, national pharmacare legislation, and addressing local health needs in Brampton.
Diabetes, one of Canada’s most prevalent chronic diseases, affects the lives of millions across the country including one in six residents in Brampton. Today’s discussion centered around the urgency and necessity of confronting this health challenge head-on. The Federal Pharmacare Act, a cornerstone of the government’s health agenda, proposes foundational principles for a national universal pharmacare program in Canada, setting the stage for universal, single-payer coverage of essential medications, including those for diabetes and contraception.
While Brampton physicians have attracted PM Justin Trudeau’s attention to the city’s particular health care requirements, from pharmacare to diabetic treatments.
Osler claims Brampton has the highest diabetes prevalence in Ontario due to its rapid growth and ethnic diversity.
Actually, Canada lacked a national pharmacare program until February 2024. Political parties, media outlets, and campaigning organizations persist in advocating for comprehensive universal pharmacare proposals. There was a decline in interest in a nationwide medication program, believed to be due to the expensive cost.
Right before the March 1, 2024, deadline, the Trudeau government revealed a revised pharmacare plan to uphold the Liberal-New Democrat supply-and-confidence agreement and avoid an unnecessary election.
The new basic pharmacare scheme will be overseen by provinces and territories. The store will focus solely on providing diabetes and contraceptive medications. Expanding the programs into various medical sectors may not lead to immediate results. Provincial pharmacare programs help with expenses for purchasing medication, whether from local pharmacies or online, until the new plan is put into action.
Thinking about Canadian diabetic peoples, MP Sonia Sidhu introduced Motion M-118 in the House of Commons on February 6, 2017, calling for the Standing Committee on Health to look into diabetes and prediabetes. The proposal received unanimous approval from the Standing Committee on Health.
With this approval, the National Framework for Diabetes, initiated as Private Member’s Bill C-237, represents the result of extensive work to improve the well-being of individuals with diabetes nationwide. This framework offers a unified direction to coordinate collective efforts nationwide in prevention, research, treatment, and more, bringing hope for millions of Canadians.
To continue to work on this, MP Sidhu managed a $7.7 million investment from the Ministry of Health Canada in Type 1 diabetes research in collaboration with JDRF.
Diabetes significantly impacts Canada’s healthcare system, with an estimated annual cost of $15.9 billion in direct and indirect expenses. By 2025, diabetes is projected to impact 1 in 6 residents.
On February 29, 2024, MP Sonia Sidhu and Minister of Health Mark Holland unveiled the Government of Canada’s national pharmacare legislation aimed at improving Canadians’ access to vital diabetes medications and devices.
Moving forward with the global counter partners In March 2021, a partnership between Canada and the Netherlands was announced to fund research on type 2 diabetes. CIHR will provide $2 million over the next 5 years to support the initiative.
In September 2017, MP Sidhu released a document titled “Defeating Diabetes,” which summarizes expert opinions on the needs of Canadians with or at risk of diabetes. The document emphasizes the significance of a revised National Diabetes Strategy that considers the diverse needs of Canadians nationwide.
MP Sidhu emphasized the importance of the Framework and Pharmacare Act in enhancing health equity, affordability, and outcomes for Canadians. One in four Canadians with diabetes are unable to follow their treatment plan due to high costs, highlighting the importance of implementing the Pharmacare Act as a significant step for those in need.
Canadian hospitals Integrated Health and Wellness are recognized for their efforts in diabetes research, emphasizing the importance of increased access to diabetes medications for the health of over 11 million Canadians with the disease and to prevent severe complications like blindness or amputations.
